Trademark: 79239267
Status Date
Tuesday, June 11, 2019
Registration Number
5772180
Registration Date
Tuesday, June 11, 2019
Filing Date
Monday, June 25, 2018
Published for Opposition
Tuesday, March 26, 2019
5 Biopharmaceutical preparations for use in the treatment of hypertension, strokes, cardiac diseases and vascular diseases; diagnostic medical reagents, chemicals preparations and biological materials all the foregoing being in the form of spatially defined arrays and solutions and reagents for medical laboratory use in diagnosting, monitoring, and predicting diseases and for measuring and predicting response to therapy of cardiac and vascular diseases; pharmaceutical preparations for use in the treatment of hypertension, strokes, cardiac diseases and vascular diseases; pharmaceutical substances and medicines for treatment or prevention of eye disorders and diseases and of ophthalmological disorders and diseases; pharmaceutical preparations and substances for the treatment or prevention of diabetes; medicines for treating or preventing diabetes; ophthalmic medicines and surgical fluids, ophthalmic pharmaceutical preparations; pharmaceutical eye drops
42 Scientific and technological services, namely research and design relating thereto in the field of ophthalmology, in the field of diabetes and in the field of treatment of cardiovascular disease, cardiac disease and vascular disease; industrial analysis of the pharmaceutical preparations of others used for the treatment of ophthalmologic diseases, diabetes and cardiovascular diseases for quality control purposes; research services in the field of ophthalmology, diabetes and cardiovascular diseases; pharmaceutical and biopharmaceutical research and development; biopharmaceutical product evaluation; research in the field of treatment of cardiovascular disease, cardiac disease, and vascular disease; development of new treatments for pathologies in which vascular biology plays a critical role in the field of biopharmaceuticals
44 Medical services; veterinary services; consultancy services, namely, consultancy in the medical, veterinary and pharmaceutical treatment of patients in the fields of ophthalmology, diabetes and cardiovascular diseases; medical services, namely, cardiac and vascular therapeutic, prognostic and diagnostic testing services
Oct 12, 2019
Final Decision Transaction Processed By Ib
Sep 21, 2019
Final Disposition Notice Sent To Ib
Sep 21, 2019
Final Disposition Processed
Sep 11, 2019
Final Disposition Notice Created, To Be Sent To Ib
Jun 13, 2019
Change Of Name/Address Rec'd From Ib
Jun 11, 2019
Registered-Principal Register
Mar 26, 2019
Official Gazette Publication Confirmation E-Mailed
Mar 26, 2019
Published For Opposition
Mar 23, 2019
Notification Processed By Ib
Mar 6, 2019
Notification Of Possible Opposition Sent To Ib
Mar 6, 2019
Notification Of Notice Of Publication E-Mailed
Mar 6, 2019
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Feb 15, 2019
Assigned To Lie
Feb 2, 2019
Approved For Pub - Principal Register
Jan 30, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 30, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 30, 2019
Teas/Email Correspondence Entered
Jan 30, 2019
Correspondence Received In Law Office
Jan 30, 2019
Teas Response To Office Action Received
Nov 9, 2018
Refusal Processed By Ib
Oct 25, 2018
Non-Final Action Mailed - Refusal Sent To Ib
Oct 25, 2018
Refusal Processed By Mpu
Oct 14, 2018
Non-Final Action (Ib Refusal) Prepared For Review
Oct 13, 2018
Non-Final Action Written
Oct 13, 2018
Assigned To Examiner
Aug 28, 2018
Application Filing Receipt Mailed
Aug 24, 2018
New Application Office Supplied Data Entered In Tram
Aug 23, 2018
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
